Industry Inscript (Page 1)

Latest

Pfizer-Backed VitaDAO Community Approves Launch and Financing of Its First Longevity Biotech Company

Pfizer-backed VitaDAO marks a milestone, launching Matrix Biosciences, their first longevity-focused biotech company, aiming to unlock breakthroughs in extending human life. Dr. Vera Gorbunova leads the venture, exploring the secrets of cancer-resistant naked mole-rats.

Axolotl Biologix and Carmell Therapeutics Merge to Pioneer Regenerative Medicine Advancements

Flagstaff's Axolotl Biologix merges with Carmell Therapeutics, a major move in regenerative medicine. $65 million initial value with potential for $75 million more in milestone payments. Pioneering innovations expected in soft tissue repair and orthopedics.